HLF Herbalife (HLF) Insider Trading, Ownership & Congress Trades
Wholesale & Retail · Wholesale-drugs, proprietaries & druggists' sundries · CIK 0001180262
SEC filings
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
132
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $775.5K priced
What the filings say about HLF
Insiders, 180 days
-$2.5M net sold
1 buyer · 2 sellers · 0% of sales under a 10b5-1 plan
Herbalife insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, HERBALIFE LTD. insiders sold a net $2.5M of stock across 54 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 buys), the last on Dec 1, 2025.
- +46.9% median (+22.0% mean) 90-day return after 3 previous buys.
- The trade is 1.5% of the 79,882 shares held after it.
- No other insider bought within 30 days.
- 132 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director L'Helias Sophie bought about $13.6K of HLF on Jun 4, 2026; 132 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on May 18, 2026.
- The trade is 103.0% of the 9,706 shares held after it.
- 1 other insider sold within 30 days.
- 132 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Operating Officer Hicks Troy sold about $123.2K of HLF on May 19, 2026; 1 other insider sold within 30 days and 132 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 423.5% of the 9,062 shares held after it.
- 1 other insider sold within 30 days.
- 132 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Operating Officer Hicks Troy sold about $496.2K of HLF on May 18, 2026; 1 other insider sold within 30 days and 132 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on May 11, 2026.
- The trade is 368.6% of the 36,624 shares held after it.
- 1 other insider sold within 30 days.
- 132 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Commercial Officer Lamberti Frank sold about $1.8M of HLF on May 12, 2026, the largest insider sale at the company since 2022; 1 other insider sold within 30 days and 132 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 4.6% of the 171,606 shares held after it.
- 1 other insider sold within 30 days.
- 132 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Commercial Officer Lamberti Frank sold about $110.0K of HLF on May 11, 2026, the largest insider sale at the company since 2022; 1 other insider sold within 30 days and 132 funds added in the latest 13F quarter.54 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$2.5M over 180 days
below 60% of Wholesale & Retail
Congress
no House purchase disclosed in the last 12 months
Funds
132 funds bought in last quarter
more than 58% of Wholesale & Retail
Revenue
+0.9% year over year
below 61% of Wholesale & Retail
Margin
4.5% net margin
more than 71% of Wholesale & Retail
Buybacks
$10.0M repurchased, FY to 2026-06-30
below 65% of Wholesale & Retail
Short interest
9.4% of the float short (float per yahoo 2026-10-27) · 5.5 days to cover · settled 2026-10-15
more than 76% of Wholesale & Retail
What changed in the last 30 days
Oct 28Insider selling stopped: no sales in 90 days after 4 in the prior 90
Why it matters
The absence is the signal: 4 sales in one 90-day window and none in the next is a change of behaviour, not a filing.
Watch HLF
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+56.1%12M
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns HLF: institutional holders (13F)
13F holdings, latest reported quarter
8,371,046 sh
$110.1M
8,348,800 sh
$109.8M
6,192,277 sh
$81.4M
5,024,668 sh
$66.1M
4,411,900 sh
$58.0M
Congress trades in HLF
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
HLF planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
HLF mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Invesco Food & Beverage ETF
$3.0M position · as of 2026-07-31
2.8%
Victory RS Partners Fund
$9.1M position · as of 2026-06-30
1.3%
Inspire Fidelis Multi Factor ETF
$1.4M position · as of 2026-05-31
0.7%
Applied Finance IVS US SMID ETF
$140.2K position · as of 2026-06-30
0.5%
LSV Small Cap Value Fund
$2.3M position · as of 2026-07-31
0.3%
SEI Select Small Cap ETF
$1.5M position · as of 2026-06-30
0.3%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Dr.John Agwunobi
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2021
$7.0M
$3.7M
$2.3M
-14%
+14%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $2.5M sold by insiders over 180 days, 132 funds added last quarter. Each figure is a federal filing, dated the day it went public.
HLF financials
Revenue growth
+0.9%
XBRL, annual
Net margin
4.5%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$5.2B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM HLF
| FY Dec 2025 | $5.0B |
| FY Dec 2024 | $5.0B |
| FY Dec 2023 | $5.1B |
| FY Dec 2022 | $5.2B |
| FY Dec 2021 | $5.8B |
| Jun 2026 | $1.3B |
| Mar 2026 | $1.3B |
| Dec 2025 | $1.3B |
| Sep 2025 | $1.3B |
| Jun 2025 | $1.3B |
| Mar 2025 | $1.2B |
| Dec 2024 | $1.2B |
| Sep 2024 | $1.2B |
At each fiscal year end
Single quarter
Net margin, TTM
+3.2%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM HLF
| FY Dec 2025 | +4.5% |
| FY Dec 2024 | +5.1% |
| FY Dec 2023 | +2.8% |
| FY Dec 2022 | +6.2% |
| FY Dec 2021 | +7.7% |
| Jun 2026 | -2.0% |
| Mar 2026 | +4.7% |
| Dec 2025 | +6.7% |
| Sep 2025 | +3.4% |
| Jun 2025 | +3.9% |
| Mar 2025 | +4.1% |
| Dec 2024 | +14.7% |
| Sep 2024 | +3.8% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$322.3M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM HLF
| FY Dec 2025 | $252.9M |
| FY Dec 2024 | $163.4M |
| FY Dec 2023 | $222.5M |
| FY Dec 2022 | $196.1M |
| FY Dec 2021 | $308.9M |
| Jun 2026 | $21.6M |
| Mar 2026 | $102.9M |
| Dec 2025 | $79.8M |
| Sep 2025 | $118.0M |
| Jun 2025 | $73.2M |
| Mar 2025 | -$18.1M |
| Dec 2024 | $43.9M |
| Sep 2024 | $72.4M |
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity HLF
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.19x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt HLF
| FY Dec 2025 | 0.17x |
| FY Dec 2024 | 0.13x |
| FY Dec 2023 | 0.14x |
| FY Dec 2022 | 0.13x |
| FY Dec 2021 | 0.17x |
| Jun 2026 | 0.19x |
| Mar 2026 | 0.22x |
| Dec 2025 | 0.17x |
| Sep 2025 | 0.15x |
| Jun 2025 | 0.12x |
| Mar 2025 | 0.12x |
| Dec 2024 | 0.13x |
| Sep 2024 | 0.14x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
average equity is zero or negative
Return on equity HLF
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+5.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets HLF
| FY Dec 2025 | +8.3% |
| FY Dec 2024 | +9.2% |
| FY Dec 2023 | +5.1% |
| FY Dec 2022 | +11.6% |
| FY Dec 2021 | +15.2% |
| Jun 2026 | +5.9% |
| Mar 2026 | +8.6% |
| Dec 2025 | +8.3% |
| Sep 2025 | +12.0% |
| Jun 2025 | +12.2% |
| Mar 2025 | +10.5% |
| Dec 2024 | +9.2% |
| Sep 2024 | +3.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+34.1%
operating income after a 23.6% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital HLF
| FY Dec 2025 | +41.9% |
| FY Dec 2024 | n/a |
| FY Dec 2023 | +29.1% |
| FY Dec 2022 | +51.0% |
| FY Dec 2021 | +71.8% |
| Jun 2026 | +34.1% |
| Mar 2026 | +39.6% |
| Dec 2025 | +41.9% |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | +27.6% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+27.9%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed HLF
| FY Dec 2025 | +29.4% |
| FY Dec 2024 | +25.5% |
| FY Dec 2023 | +21.7% |
| FY Dec 2022 | +31.2% |
| FY Dec 2021 | +39.8% |
| Jun 2026 | +27.9% |
| Mar 2026 | +29.1% |
| Dec 2025 | +29.4% |
| Sep 2025 | +31.8% |
| Jun 2025 | +29.9% |
| Mar 2025 | +26.8% |
| Dec 2024 | +25.5% |
| Sep 2024 | +22.9% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
8.51x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing HLF
| FY Dec 2025 | 5.83x |
| FY Dec 2024 | 2.68x |
| FY Dec 2023 | 10.75x |
| FY Dec 2022 | 4.62x |
| FY Dec 2021 | 9.91x |
| Jun 2026 | 8.43x |
| Mar 2026 | 6.43x |
| Dec 2025 | 5.83x |
| Sep 2025 | 2.69x |
| Jun 2025 | 2.71x |
| Mar 2025 | 3.14x |
| Dec 2024 | 2.68x |
| Sep 2024 | 8.46x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$3.0B
market value at close 2026-10-26 on 2026-07-29 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value HLF
| FY Dec 2025 | $3.0B |
| FY Dec 2024 | $2.5B |
| FY Dec 2023 | $3.5B |
| FY Dec 2022 | $3.6B |
| FY Dec 2021 | $6.8B |
| Jun 2026 | $3.0B |
| Mar 2026 | $3.1B |
| Dec 2025 | $3.0B |
| Sep 2025 | $2.6B |
| Jun 2025 | $2.7B |
| Mar 2025 | $2.7B |
| Dec 2024 | $2.5B |
| Sep 2024 | $2.6B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+23.2%
TTM free cash flow over market value at close 2026-10-26
FCF yield HLF
| FY Dec 2025 | +19.0% |
| FY Dec 2024 | +24.2% |
| FY Dec 2023 | +14.7% |
| FY Dec 2022 | +13.5% |
| FY Dec 2021 | +6.7% |
| Jun 2026 | +23.6% |
| Mar 2026 | +24.6% |
| Dec 2025 | +19.0% |
| Sep 2025 | +24.9% |
| Jun 2025 | +19.5% |
| Mar 2025 | +18.8% |
| Dec 2024 | +24.2% |
| Sep 2024 | +24.9% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -51%, PEG needs growth
PEG, trailing HLF
| FY Dec 2025 | n/a |
| FY Dec 2024 | 0.04x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 0.20x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | 0.01x |
| Jun 2025 | 0.01x |
| Mar 2025 | 0.03x |
| Dec 2024 | 0.04x |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $5.0B | $5.0B | $5.1B | $5.2B |
| Gross profit | $3.9B | $3.9B | $3.9B | $4.0B |
| Operating income | $481.0M | $385.9M | $356.4M | $545.2M |
| Net income | $228.3M | $254.3M | $142.2M | $321.3M |
| EPS (diluted) | 2.20 | 2.50 | 1.42 | 3.23 |
| Operating cash flow | $333.3M | $285.4M | $357.5M | $352.5M |
| Cash | $353.1M | $415.3M | $575.2M | $508.0M |
| Long-term debt | $2.0B | $2.0B | $2.3B | $2.7B |
| Buybacks | $8.2M | $8.3M | $11.0M | $146.7M |
SEC XBRL, fiscal years, as known on 2026-10-28
HLF Stock Sonar score 6/7 axes
Find similar shapesCompareHLF ranks highest on profitability (80th percentile) and risk and compliance (69th), and lowest on growth (39th), among Wholesale & Retail peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HLF filings, in plain words
Are Herbalife insiders buying or selling HLF?
In the 180 days to 2026-10-28, Herbalife insiders were net sellers, a net $2.5M: $13.6K of purchases and $2.6M of sales reported on Form 4, by 1 buyer and 2 sellers.
Read the full summary
In the 180 days to 2026-10-28, Herbalife insiders were net sellers of HLF, a net $2.5M across purchases and sales reported on Form 4 by 1 buyer and 2 sellers. Sales outweighed purchases more than tenfold by value. None of the 4 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
